ClinicalTrials.gg
Not yet recruitingNCT07397702Updated Feb 9, 2026

Effects of HIIT and MICT Training on Cardiorespiratory Fitness, Testosterone/Cortisol Ratio, and Mental Health in Young Adults

An interventional study of High-intensity interval training and Moderate-intensity continuous training in Exercise, sponsored by Universidad de Colima. Not yet recruiting. Open to participants aged 18 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-09.

Primary conditionMotor Activity(the registry's first term)UnverifiedIs this wrong?Motor Activity is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Universidad de Colima · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years to 21 Years
Sex
All
01

Study summary

This study will use a randomized, double-blind clinical trial to evaluate the effects of eight-week HIIT and MICT exercise programs on cardiorespiratory fitness, the testosterone/cortisol ratio, and mental health in 68 healthy, moderately active young adults aged 18 to 21. Participants will be assigned to parallel groups based on their sex and training type (HIIT men, HIIT women, MICT men, MICT women). The key metrics will be measured both before and after the intervention period to assess the impact of the different training regimens.

Read the detailed description

This randomized, double-blind clinical trial will investigate the effects of high-intensity interval training (HIIT) versus moderate-intensity continuous training (MICT) on cardiorespiratory fitness and symptoms of anxiety and depression in high school students.

The study will recruit 68 male and female students, aged 15-19, who are moderately inactive. Participants will be randomized into HIIT or MICT groups, stratified by gender. The 8-week intervention consists of three weekly sessions: HIIT involves 10x1-minute high-intensity intervals, while MICT consists of 30 minutes of continuous running. Cardiorespiratory fitness (measured via the Course Navette test to estimate VO₂max) and mental health symptoms (using Beck inventories) will be assessed before and after the intervention.

The primary hypothesis is that HIIT will yield greater improvements in VO₂max and greater reductions in anxiety and depression symptoms compared to MICT. Statistical analysis will employ ANOVA and related tests to evaluate changes within and between groups, with a significance level set at p\<0.05. The study aims to provide evidence for designing personalized exercise programs that optimize both physical and mental health in adolescents.

02

Conditions studied

  • Exercise

Browse trials for

Keywords

  • High-Intensity Interval Training
  • Aerobic Exercise
  • Testosterone
  • Cortisol
  • Anxiety Disorders
  • Depressive Disorder
03

In context

Motor Activity Unverified

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

This study's planned enrollment of 76 is above the median of 60 across 8,388 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Universidad de Colima is the lead sponsor of 12 studies on the registry; 4 are open to participants now.

Compared within Motor Activity, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women aged 18 to 21.
  • Lead a sedentary or moderately active lifestyle (IPAQ ≤600 METs-min/week).
  • Subjects diagnosed by a physician as fit for physical exercise.
  • form signed by the study subjects.

Exclusion criteria

Exclusion criteria:

  • Subjects with any motor disability.
  • Pregnant women.
  • Subjects with metabolic disorders.
  • Subjects with chronic respiratory diseases such as asthma, emphysema, or cancer, obstructive pulmonary disease.
  • Subjects with high blood pressure or arrhythmia.
  • Failure to sign the form.
  • Subjects who are in a high-performance physical training program.
  • Women with irregular menstrual cycles who take medication to regulate their menstrual cycle.
  • Consumption of caffeine, alcohol, and tobacco or use of electronic cigarettes.
  • Subjects with a cyclical diagnosis of anxiety and depression by a specialist.
  • Frequent consumption of alcoholic beverages (more than 7 drinks per week for women and more than 14 drinks per week for men) or a history of excessive alcohol consumption.
  • Subjects who consume dietary supplements (caffeine, nitric oxide precursors, beta-alanine, creatine, sodium bicarbonate, or L-carnitine).

Elimination criteria:

  • Voluntary withdrawal from the study.
  • Attendance at less than 80% of intervention sessions.
  • Incomplete measurement schedule or insufficient sample size.
  • Joint or muscle injuries caused by the training program.
  • Overtraining syndrome.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Experimental
    Group A: high-intensity interval training program

    High-intensity interval training (HIIT) sessions will consist of continuous running for a 5-minute warm-up at 75% of maximum heart rate (HRmax), followed by 10 repetitions of intermittent running in 1-minute intervals at 85-90% of HRmax, intercalated with 1-minute recovery periods at 50-60% of HRmax. There will be 3 sessions per week (75-minute weekly training). All HIIT intervention sessions end with a cool-down walk and stretching.

    Other: High-intensity interval training

  • Active comparator
    Group B: moderate-intensity continuous training program

    Moderate-intensity continuous training (MICT) sessions will consist of running continuously for 30 minutes at an intensity of 60-70% of HRmax, with a frequency of 3 sessions per week (60 minutes of training per week). All sessions with MICT intervention end with a cool-down walk and stretching.

    Other: Moderate-intensity continuous training

Interventions

  • OtherHigh-intensity interval training

    The intervention involves physical exercise with the aim of observing any changes that may occur in mental health and hormonal parameters. However, the magnitude of these effects and the type of exercise that is most effective in reducing symptoms of anxiety and depression are still unknown.

  • OtherModerate-intensity continuous training

    The intervention involves physical exercise with the aim of observing any changes that may occur in mental health and hormonal parameters. However, the magnitude of these effects and the type of exercise that is most effective in reducing symptoms of anxiety and depression are still unknown.

06

What researchers measure

Primary outcomes

  1. Symptoms of anxiety from baseline to eight weeks.

    The measurement of anxiety symptoms will be conducted using the Beck Anxiety Inventory (BAI) in printed format, which is a validated psychological tool used to assess the severity of anxiety symptoms in adults. The total score is interpreted on a scale from 0 to 63, where a score of 0 indicates the absence of anxiety symptoms, and higher scores reflect increasing levels of anxiety, with the upper values representing severe anxiety.

    Time frame: Baseline and week 8 of training.

  2. Symptoms of depression from baseline to eight weeks.

    The measurement of depression symptoms will be conducted using the Beck Depression Inventory (BDI) in printed format, which is a validated psychological tool used to assess the severity of depression symptoms in adults. The total score is interpreted on a scale from 0 to 63, where a score of 0 indicates the absence of depression symptoms, and higher scores reflect increasing levels of depression, with the upper values representing severe depression.

    Time frame: Baseline and week 8 of training.

  3. Testosterone levels using the ELISA method

    Testosterone and cortisol levels will also be determined in picograms per milliliter (pg/mL) using the enzyme-linked immunosorbent assay (ELISA) method, which is employed to quantify hormones, cytokines, and other proteins in blood or other biological fluids.

    Time frame: Baseline and week 8 of training.

  4. Cortisol levels using the ELISA method

    Cortisol levels will also be determined in picograms per milliliter (pg/mL) using the enzyme-linked immunosorbent assay (ELISA) method, which is employed to quantify hormones, cytokines, and other proteins in blood or other biological fluids.

    Time frame: Baseline and week 8 of training.

  5. Cardiorespiratory capacity using VO₂max

    Cardiorespiratory capacity will be assessed using the 20-meter run test, with maximal oxygen uptake (VO₂max), expressed in millilitres per minute per kilogram (mL/kg/min), as the main indicator. The test consists of running back and forth between two points separated by 20 meters, following a pace dictated by auditory signals; as the test progresses, the running speed gradually increases.

    Time frame: Baseline and week 8 of training.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Velasco-Orjuela GP, Dominguez-Sanchez MA, Hernandez E, Correa-Bautista JE, Triana-Reina HR, Garcia-Hermoso A, Pena-Ibagon JC, Izquierdo M, Cadore EL, Hackney AC, Ramirez-Velez R. Acute effects of high-intensity interval, resistance or combined exercise protocols on testosterone - cortisol responses in inactive overweight individuals. Physiol Behav. 2018 Oct 1;194:401-409. doi: 10.1016/j.physbeh.2018.06.034. Epub 2018 Jun 22. PubMed 29940266 ↗
  • Paolucci EM, Loukov D, Bowdish DME, Heisz JJ. Exercise reduces depression and inflammation but intensity matters. Biol Psychol. 2018 Mar;133:79-84. doi: 10.1016/j.biopsycho.2018.01.015. Epub 2018 Feb 3. PubMed 29408464 ↗

Individual participant data

Plan to share: Yes — the plan to share information with other researchers through the publication of different articles that can be extracted from the research

Supporting information: Study protocol, Informed consent form

Time frame: The information will be available as of August 2026

Access criteria: To have access to these data, other researchers must be performing the same methodological design, so there is no point in sharing it with a different study design

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07397702
Lead sponsor
Universidad de Colima
Responsible party
Pedro Julian Flores Moreno (Ph. D. in Science, Universidad de Colima) — Principal investigator
First posted
Feb 9, 2026
Start date
May 25, 2026 (estimated)
Primary completion
Jul 24, 2026 (estimated)
Completion
Aug 7, 2026 (estimated)
Last update
Feb 9, 2026

Study contacts

Luis Jaime Orozco Milanez, M. Sc.
Contact
lorozco2@ucol.mx
+(52) 312 209 5656
Pedro Julián Flores Moreno
study chair · Universidad de Colima

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion